News

Scientists develop new drug for virus affecting lakhs each year, offers 99.9% protection with two injections, it is priced at Rs...
More than a million people are infected every year with the Human Immunodeficiency Virus (HIV), despite decades of work ...
Daily Excelsior35mOpinion
Trump creating a global health crisis by withdrawing funds from HIV vaccine research
By C.J. Atkins Just in time for Pride month, President Donald Trump and Health Secretary Robert F. Kennedy, Jr., have ...
Gilead's bi-annual HIV prevention jab gets FDA approval: How much does it cost and how it works? All you need to know…
Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent ...
WAPT41m
Twice-a-year HIV prevention shot Yeztugo could be a game changer for Jackson and beyond
The FDA has approved Yeztugo, the first long-acting injectable PrEP shot, which could significantly impact HIV prevention ...
Mother Jones1h
FDA Approves “Breakthrough” HIV Drug
On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...
FDA Approves New Injection For HIV Prevention
The U.S. Food and Drug Administration approved an HIV prevention medication that has been proven highly effective in clinical ...
Zimbabwe Situation2h
Twice-a-year shot to prevent HIV could stop transmission — if people can get it
Men, women, gay, straight – it really just kinds of expands the opportunity for prevention’ Source: Twice-a-year shot to prevent HIV could stop transmission — if people can get it – Zimbabwe News Now ...
Queerty2h
FDA approves world’s first twice-yearly PrEP injection
The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...
Zacks Investment Research on MSN4h
FDA Approves Gilead's Twice-Yearly Shot for HIV Prevention
Gilead Sciences, Inc. GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Dallas Voice4h
FDA approves first twice-a-year PrEP injectable
The U.S. Food and Drug Administration this week approved Gilead Sciences’ twice-a-year shot, lenacapvir, to prevent HIV, Gilead announced on Wednesday, June 18. It is the first and only long-acting ...